Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026

Jake Scott; Michael S. Abers; Harleen Marwah; Nicole C. McCann; Eric A. Meyerowitz; Aaron Richterman; Derek Fleming; Evelyn M. Holmes; Leah E. Moat; Sydney G. Redepenning; Emily Smith; Cheryl A. Stoddart; Maria E. Sundaram; Angela K. Ulrich; Christopher Alba; Cory Anderson; Meredith Arpey; Ethan D. Borre; Joseph Ladines-Lim; Angela J Mehr; Katherine M. Rich; Corey D. Watts; Nicole E. Basta; Jana Jarolimova; Rochelle P. Walensky; Caitlin M. Dugdale

doi:10.1056/nejmsa2514268

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Ongoing peer-reviewed evidence supports the safety and effectiveness of immunizations against Covid-19, RSV, and influenza during the 2025-2026 season. (Funded by the Center for Infectious Disease Research and Policy and the Alumbra Innovations Foundation.).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Scott et al. (2025) studied this question.

synapsesocial.com/papers/69de516da051b8e25be93be6 https://doi.org/10.1056/nejmsa2514268

View at Publisher

Ask AI

Bookmark

Share

Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026

Ask about this paper

Abstract

Discussion

Cite This Study

Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading